Seastar Medical Says Clinical Trial Results Demonstrate Its SCD Significantly Lowered Mortality Rates Among Critically Ill Covid-19 Patients

T-Reuters
Jun 07, 2022

LMF Acquisition Opportunities Inc :Seastar Medical Announces Publication Of Clinical Trial Results Demonstrating Its Scd Significantly Lowered Mortality Rates Among Critically Ill Icu Covid-19 Patients By Safely And Effectively Stopping Inflammation Causing Cytokine Storms.Seastar Medical - Patients Experienced Reductions In Activated Neutrophils And Monocytes.Seastar Medical - Reductions In Activated Neutrophils, Monocytes, Led To Reduction In Proinflammatory Cytokines And Improved Clinical Outcomes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10